Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING OVERACTIVE BLADDER
Document Type and Number:
WIPO Patent Application WO/2023/113114
Kind Code:
A1
Abstract:
The present invention relates to: a novel quinazoline-based compound for activating BKCa channels; and a use thereof for preventing or treating an overactive bladder. The compound of the present invention can effectively activate BKCa channels, and thus can be used for preventing or treating an overactive bladder caused by the inactivation or an activity decrease of BKCa channels.

Inventors:
PARK CHUL SEUNG (KR)
AHN JIN HEE (KR)
JO HEE JI (KR)
BAE EUN JUNG (KR)
Application Number:
PCT/KR2022/006678
Publication Date:
June 22, 2023
Filing Date:
May 10, 2022
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
GWANGJU INST SCIENCE & TECH (KR)
International Classes:
C07D495/04; A61K31/519; A61P13/10
Foreign References:
US20200222416A12020-07-16
US20150284387A12015-10-08
US20090175805A12009-07-09
Other References:
LIM DONG HOON, MOON HYOUNG YOON, RHO JOON, KIM CHEOL SUNG: "Isolation of Methicillin-Resistant Staphylococcus aureus from the Urinary Tract: Clinical Characteristics and Antimicrobial Resistance ", KOREAN JOURNAL OF UROGENITAL TRACT INFECTION INFLAMMATION, vol. 3, no. 2, 1 October 2008 (2008-10-01), pages 208 - 214, XP093072601
KANT SASHI, ASTHANA SHAILENDRA, MISSIAKAS DOMINIQUE, PANCHOLI VIJAY: "A novel STK1-targeted small-molecule as an “antibiotic resistance breaker” against multidrug-resistant Staphylococcus aureus", SCIENTIFIC REPORTS, vol. 7, no. 1, XP093072602, DOI: 10.1038/s41598-017-05314-z
Attorney, Agent or Firm:
LEECHAE INTELLECTUAL PROPERTY (KR)
Download PDF: